Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-03-26 to 2025-03-27
Current total value of award: $46.65
Description: 4567699215!MIDAZOLAM HCL 5 MG/ML VIALML